Should I Buy SCHD in 2026? 22 Stock Changes & Reconstitution Explained Guide

The Schwab US Dividend Equity ETF, widely known by its ticker SCHD, remains a cornerstone for income-focused investors due to its rigorous, rules-based selection process. Unlike actively managed funds that rely on human intuition, SCHD operates on a proprietary algorithm designed to identify high-quality, sustainable dividend-paying companies. To even be considered for the fund, a company must demonstrate a minimum of 10 consecutive years of dividend payments and maintain a market capitalization of at least $500 million. This baseline ensures that only established players with proven track records enter the ecosystem, providing a safety net against speculative volatility.

Once the initial criteria are met, the algorithm ranks candidates based on several fundamental quality metrics. These include cash flow to total debt, return on equity (ROE), dividend yield, and the five-year dividend growth rate. This multi-layered screening process is what separates SCHD from simple high-yield traps that offer attractive payouts but lack the underlying financial health to sustain them. By focusing on quality and growth, the fund aims to provide both immediate income and long-term capital appreciation.

To prevent any single stock from dominating the portfolio and introducing idiosyncratic risk, SCHD implements a strict 4% weighting cap on individual holdings. While a stock's value may fluctuate and cause it to exceed this limit temporarily, the fund undergoes quarterly rebalancing to bring positions back in line. This systematic approach enforces a 'buy low, sell high' discipline without the emotional interference of a human fund manager, ensuring the portfolio remains diversified across its top 100 holdings.

This methodology has historically allowed SCHD to outperform many of its peers in the dividend growth category. By prioritizing sustainable cash flow over raw yield, the fund positions itself as a core holding for those seeking a balance between safety and performance. For the modern investor, understanding these mechanics is essential for integrating the fund into a broader asset allocation strategy.

The annual reconstitution of SCHD is a major event in the financial calendar, often referred to as 'reshuffling the deck.' In 2026, the fund saw the removal of 22 stocks and the addition of 25 new components. This shift represents a significant tactical pivot in response to changing market conditions and individual company performance. Perhaps the most shocking exits were Cisco Systems (CSCO) and AbbVie (ABBV). These companies have been staples of the dividend world for years, but the algorithm determined that other opportunities currently offer a better combination of yield and growth potential.

Replacing these tech and healthcare giants are notable names like UnitedHealth Group (UNH) and Qualcomm. UnitedHealth Group, despite recent market pressures, brings a massive footprint in the healthcare sector and a strong history of dividend growth. Similarly, Qualcomm offers exposure to the semiconductor space but with a valuation and yield profile that fits the SCHD criteria more closely than the hyper-growth tech stocks currently leading the broader market. The inclusion of Macy's was another surprise, highlighting the fund's willingness to rotate into deep-value retail when the metrics align.